These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6106696)

  • 1. On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms.
    Costall B; Fortune DH; Granchelli FE; Law SJ; Naylor RJ; Neumeyer JL; Nohria V
    J Pharm Pharmacol; 1980 Aug; 32(8):571-6. PubMed ID: 6106696
    [No Abstract]   [Full Text] [Related]  

  • 2. Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist.
    Neumeyer JL; Law SJ; Baldessarini RJ; Kula NS
    J Med Chem; 1980 Jun; 23(6):594-5. PubMed ID: 7392026
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissociation between behavioral effects of (-)-N-(2-chloroethyl)-norapomorphine and D2 dopamine receptor-like activity.
    Helmeste DM
    Eur J Pharmacol; 1983 Nov; 95(3-4):277-81. PubMed ID: 6317413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of (-)N-(chloroethyl)-norapomorphine on [3H]-apomorphine binding to striatal dopamine receptors.
    Goosey MW; Doggett NS
    Biochem Pharmacol; 1982 Nov; 31(22):3693-4. PubMed ID: 7181954
    [No Abstract]   [Full Text] [Related]  

  • 5. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.
    Costall B; Naylor RJ
    J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
    Miller RJ; Kelly PH; Neumeyer JL
    Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)N-(chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor binding.
    Costall B; Fortune DH; Law SJ; Naylor RJ; Neumeyer JL; Nohria V
    Nature; 1980 Jun; 285(5766):571-3. PubMed ID: 7402299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor inhibition induced by aporphine derivatives in the mouse.
    Bradbury AJ; Costall B; Naylor RJ; Neumeyer JL
    J Pharm Pharmacol; 1983 Aug; 35(8):494-9. PubMed ID: 6137533
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and biological activity of some aporphine derivatives related to apomorphine.
    Saari WS; King SW
    J Med Chem; 1974 Oct; 17(10):1086-90. PubMed ID: 4472802
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
    Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
    J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.
    Jenner P; Elliott PN; Clow A; Reavill C; Marsden CD
    J Pharm Pharmacol; 1978 Jan; 30(1):46-8. PubMed ID: 22724
    [No Abstract]   [Full Text] [Related]  

  • 12. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
    Ferretti C; Ghi P; Blengio M; Gaietta G; Barrera G; Genazzani E
    Eur J Pharmacol; 1989 Jul; 166(2):149-56. PubMed ID: 2551698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines.
    Neumeyer JL; Arana GW; Law SJ; Lamont JS; Kula NS; Baldessarini RJ
    J Med Chem; 1981 Dec; 24(12):1440-5. PubMed ID: 7310821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-2 dopamine receptor synthesis and turnover in rat striatum.
    Fukuchi I; Fujita N; Nakahiro M; Saito K; Yoshida H
    Eur J Pharmacol; 1986 Aug; 127(3):291-4. PubMed ID: 2944755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro.
    Baldessarini RJ; Kula NS; Arana GW; Neumeyer JL; Law SJ
    Eur J Pharmacol; 1980 Oct; 67(1):105-10. PubMed ID: 7418727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in dopamine receptors in mouse striatum following morphine treatments.
    de la Baume S; Patey G; Marçais H; Protais P; Costentin J; Schwartz JC
    Life Sci; 1979 Jun; 24(25):2333-42. PubMed ID: 573360
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
    Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
    Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
    [No Abstract]   [Full Text] [Related]  

  • 18. Dissociation by the aporphine derivatives of the stereotypic and hyperactivity responses resulting from injections into the nucleus accumbens septi.
    Costall B; Naylor RJ; Neumeyer JL
    J Pharm Pharmacol; 1975 Nov; 27(11):875-7. PubMed ID: 1503
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
    Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aporphines as antagonists of dopamine D-1 receptors.
    Schaus JM; Titus RD; Foreman MM; Mason NR; Truex LL
    J Med Chem; 1990 Feb; 33(2):600-7. PubMed ID: 2405158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.